Media Centre

Text with Title

Evaluate's commercial intelligence on the pharmaceutical, biotechnology, and medical device industries is consistently referenced by leading business and industry publications such as the Financial Times, Wall Street Journal, and Nature.

Download our latest Media Kit for a forward-looking view of top companies, products, and more to support your editorial content.

Media Kit

To learn more about how we work with healthcare and business reporters worldwide, or if you are looking for specific data and expert insights to support a current story, please contact us.

Jennifer Dinkel, Evaluate
US media & general questions

Instinctif Partners
Non-US media

Latest Press Releases

Latest Media Coverage

Nature Reviews Drug Discovery

Top product forecasts for 2019

Perhaps the most startling thing about the forecasted best-selling drugs in 2019 is the longevity of some of the entrants in the list (Table 1). Humira, once again…

Wall Street Journal

Samsung Faces Resistance From Big Pharma in the U.S.

World-wide sales of biologics totaled $271.8 billion in 2018 and are expected to rise to $290 billion this year, according to EvaluatePharma, a provider of pharmaceutical…

Vantage logo
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.